Plant-Derived Lectins as Potential Cancer Therapeutics and Diagnostic Tools.

Cancer remains a global health challenge, with high morbidity and mortality, despite the recent advances in diagnosis and treatment. Multiple compounds assessed as novel potential anticancer drugs derive from natural sources, including microorganisms, plants, and animals. Lectins, a group of highly...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International pp. 1 - 14
Autores principales: Mazalovska, Milena, Kouokam, J. Calvin
Formato: pictorial review tables/charts Journal Article
Publicado: Wiley-Blackwell 5/15/2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143229861&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 143229861
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 5/15/2020
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        143229861
        143229861
        143229861
        10.1155/2020/1631394
        143229861
      ppf: 1
      ppct: 13
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Plant-Derived Lectins as Potential Cancer Therapeutics and Diagnostic Tools.
      aug:
        au:
          Mazalovska, Milena
          Kouokam, J. Calvin
        affil: Department of Pharmacology and Toxicology, University of Louisville School of Medicine, University of Louisville, Louisville, KY 40202, USA
      sug:
        subj:
          Lectins Therapeutic Use
          Neoplasms Drug Therapy
          Neoplasms Diagnosis
          Apoptosis
          Autophagy
          Signal Transduction
      ab: Cancer remains a global health challenge, with high morbidity and mortality, despite the recent advances in diagnosis and treatment. Multiple compounds assessed as novel potential anticancer drugs derive from natural sources, including microorganisms, plants, and animals. Lectins, a group of highly diverse proteins of nonimmune origin with carbohydrate-binding abilities, have been detected in virtually all kingdoms of life. These proteins can interact with free and/or cell surface oligosaccharides and might differentially bind cancer cells, since malignant transformation is tightly associated with altered cell surface glycans. Therefore, lectins could represent a valuable tool for cancer diagnosis and be developed as anticancer therapeutics. Indeed, several plant lectins exert cytotoxic effects mainly by inducing apoptotic and autophagic pathways in malignant cells. This review summarizes the current knowledge regarding the basis for the use of lectins in cancer diagnosis and therapy, providing a few examples of plant-derived carbohydrate-binding proteins with demonstrated antitumor effects.
      pubtype: Academic Journal
      doctype:
        pictorial
        review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N